Fresenius SE & Co KGaA (FSNUY)
7.52
-0.03
(-0.40%)
USD |
OTCM |
May 01, 15:52
Fresenius Price to Book Value: 0.8067 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 30, 2024 | 0.8099 |
April 29, 2024 | 0.8013 |
April 26, 2024 | 0.7871 |
April 25, 2024 | 0.7906 |
April 24, 2024 | 0.7928 |
April 23, 2024 | 0.8035 |
April 22, 2024 | 0.7938 |
April 19, 2024 | 0.7831 |
April 18, 2024 | 0.7627 |
April 17, 2024 | 0.7681 |
April 16, 2024 | 0.7638 |
April 15, 2024 | 0.7327 |
April 12, 2024 | 0.7273 |
April 11, 2024 | 0.7327 |
April 10, 2024 | 0.7322 |
April 09, 2024 | 0.7466 |
April 08, 2024 | 0.7531 |
April 05, 2024 | 0.737 |
April 04, 2024 | 0.7273 |
April 03, 2024 | 0.7123 |
April 02, 2024 | 0.7112 |
April 01, 2024 | 0.7197 |
March 28, 2024 | 0.7263 |
March 27, 2024 | 0.7252 |
March 26, 2024 | 0.7127 |
Date | Value |
---|---|
March 25, 2024 | 0.7112 |
March 22, 2024 | 0.7187 |
March 21, 2024 | 0.7187 |
March 20, 2024 | 0.7324 |
March 19, 2024 | 0.737 |
March 18, 2024 | 0.7328 |
March 15, 2024 | 0.7295 |
March 14, 2024 | 0.7338 |
March 13, 2024 | 0.7456 |
March 12, 2024 | 0.7462 |
March 11, 2024 | 0.7456 |
March 08, 2024 | 0.7488 |
March 07, 2024 | 0.7515 |
March 06, 2024 | 0.7316 |
March 05, 2024 | 0.7402 |
March 04, 2024 | 0.7198 |
March 01, 2024 | 0.7488 |
February 29, 2024 | 0.7466 |
February 28, 2024 | 0.752 |
February 27, 2024 | 0.7584 |
February 26, 2024 | 0.7541 |
February 23, 2024 | 0.7445 |
February 22, 2024 | 0.7477 |
February 21, 2024 | 0.7584 |
February 20, 2024 | 0.7531 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5189
Minimum
Oct 12 2022
1.794
Maximum
May 03 2019
1.093
Average
1.108
Median
Feb 10 2022
Price to Book Value Benchmarks
Fresenius Medical Care AG | 0.8273 |
Affimed NV | 1.275 |
InflaRx NV | 0.7322 |
MorphoSys AG | 48.71 |
BioNTech SE | 0.9686 |
Price to Book Value Related Metrics
PS Ratio | 0.4861 |
Price to Free Cash Flow | 4.650 |
Price | 7.52 |
Earnings Yield | -3.79% |
Market Cap | 16.94B |
Operating PE Ratio | 8.775 |
Normalized PE Ratio | 36.59 |